331 related articles for article (PubMed ID: 24059327)
1. Targeted radionuclide therapy--an overview.
Dash A; Knapp FF; Pillai MR
Curr Radiopharm; 2013 Sep; 6(3):152-80. PubMed ID: 24059327
[TBL] [Abstract][Full Text] [Related]
2. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
3. [Nuclear medicine in oncotherapy].
Pávics L; Besenyi Z
Magy Onkol; 2015 Sep; 59(3):193-7. PubMed ID: 26339908
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?
Bardiès M; Buvat I
Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):5-20. PubMed ID: 21386782
[No Abstract] [Full Text] [Related]
5. Therapeutic radionuclides in nuclear medicine: current and future prospects.
Yeong CH; Cheng MH; Ng KH
J Zhejiang Univ Sci B; 2014 Oct; 15(10):845-63. PubMed ID: 25294374
[TBL] [Abstract][Full Text] [Related]
6. Relevance of radiobiological concepts in radionuclide therapy of cancer.
Kumar C; Shetake N; Desai S; Kumar A; Samuel G; Pandey BN
Int J Radiat Biol; 2016; 92(4):173-86. PubMed ID: 26917443
[TBL] [Abstract][Full Text] [Related]
7. Radiation protection in therapy with radiopharmaceuticals.
Hosono M
Int J Radiat Biol; 2019 Oct; 95(10):1427-1430. PubMed ID: 30265162
[No Abstract] [Full Text] [Related]
8. Radiobiologic principles in radionuclide therapy.
Kassis AI; Adelstein SJ
J Nucl Med; 2005 Jan; 46 Suppl 1():4S-12S. PubMed ID: 15653646
[TBL] [Abstract][Full Text] [Related]
9. Radiotargeting agents for cancer therapy.
Kassis AI
Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in radionuclide therapy.
Srivastava S; Dadachova E
Semin Nucl Med; 2001 Oct; 31(4):330-41. PubMed ID: 11710775
[TBL] [Abstract][Full Text] [Related]
11. Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
Druce MR; Lewington V; Grossman AB
Neuroendocrinology; 2010; 91(1):1-15. PubMed ID: 19590162
[TBL] [Abstract][Full Text] [Related]
12. The ARRONAX project.
Haddad F; Barbet J; Chatal JF
Curr Radiopharm; 2011 Jul; 4(3):186-96. PubMed ID: 22201708
[TBL] [Abstract][Full Text] [Related]
13. What can be expected from nuclear medicine tomorrow?
Barbet J; Kraeber-Bodéré F; Chatal JF
Cancer Biother Radiopharm; 2008 Aug; 23(4):483-504. PubMed ID: 18771353
[TBL] [Abstract][Full Text] [Related]
14. Radionuclide therapy beyond radioiodine.
Gabriel M
Wien Med Wochenschr; 2012 Oct; 162(19-20):430-9. PubMed ID: 22815123
[TBL] [Abstract][Full Text] [Related]
15. The role of nuclear medicine in the treatment of non-Hodgkin's lymphoma (NHL).
Bischof Delaloye A
Leuk Lymphoma; 2003; 44 Suppl 4():S29-36. PubMed ID: 15154740
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
Aghevlian S; Boyle AJ; Reilly RM
Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic advances of nuclear medicine in oncology].
Valdés Olmos RA; Hoefnagel CA; Bais E; Boot H; Taal B; de Kraker J; Vote PA
Rev Esp Med Nucl; 2001 Dec; 20(7):547-57. PubMed ID: 11709141
[TBL] [Abstract][Full Text] [Related]
18. Nuclear medicine in the treatment of neuroendocrine tumours--problems and perspectives.
Grzela T; Bialoszewska A; Brawura-Biskupski-Samaha R
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):444-7. PubMed ID: 17136539
[No Abstract] [Full Text] [Related]
19. Peptide receptor radionuclide therapy: an overview.
Dash A; Chakraborty S; Pillai MR; Knapp FF
Cancer Biother Radiopharm; 2015 Mar; 30(2):47-71. PubMed ID: 25710506
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
Sharkey RM; Goldenberg DM
J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
